In
the news will have a significant impact on the family in general have
researchers found that nasal sprays that are used in vaccination of
children as an alternative to injection is much better than the
traditional option, especially in young children.
It was found in the study, which included about 8,000 children in the under-five children who received the vaccine by nasal spray flu cases registered lower than the 54.9% of the others who had been vaccinated in the form of the traditional injection.
The head of vaccine research center at the University of St. Louis, Dr. Robert plush "nose spray provided better protection for children from the needles."
But the plush stressed that the study is not about to say that the injection is no longer suitable for use, because the nasal spray has not yet received approval from the U.S. Agency for Food and Drug Administration for use in this age in particular. However, the manufacturer of the injection (Medameon) has requested approval of the agency to be used officially injection with this age group.
Says study author Dr. Caerleon Bridges: "It seems that this kind of vaccination will improve methods of prevention of influenza in young children. Must first assess the risks and benefits of using this method and then obtaining the approval of the agency."
The results of the study appeared in the February issue of the journal New England Journal of Medicine.
The study included about 8,000 more children n of 249 research centers around the world. The researchers used centers in the United States and Europe, the Middle East and Asia.
The children ranged in age between 6 and 59 months were classified as randomly assigned to receive some of the traditional way vaccination by injection while others received the vaccination through nasal sprays, which bear the trade name Flomist.
Say plush that there are more of a reason why the new method is better than traditional, and these reasons that when spraying the vaccine in the nose, the immune system begins with the deployment of defenses in places that are more in need has a nose and respiratory system which places began to spread of infection because the flu virus is transmitted through the air to and from the nose to the rest of the respiratory system.
Also, this type of vaccine provides protection for many different strains of the disease.
But the plush warned of using this type of vaccination with children under the age of diagnosed lead to wheeze in the chest.
He also noted that the plush whiz could make it better not to use the new method with the Victims of respiratory crisis.
"The flu of the most dangerous diseases in young children as these are considered the main cause of transmission to family members."
It was found in the study, which included about 8,000 children in the under-five children who received the vaccine by nasal spray flu cases registered lower than the 54.9% of the others who had been vaccinated in the form of the traditional injection.
The head of vaccine research center at the University of St. Louis, Dr. Robert plush "nose spray provided better protection for children from the needles."
But the plush stressed that the study is not about to say that the injection is no longer suitable for use, because the nasal spray has not yet received approval from the U.S. Agency for Food and Drug Administration for use in this age in particular. However, the manufacturer of the injection (Medameon) has requested approval of the agency to be used officially injection with this age group.
Says study author Dr. Caerleon Bridges: "It seems that this kind of vaccination will improve methods of prevention of influenza in young children. Must first assess the risks and benefits of using this method and then obtaining the approval of the agency."
The results of the study appeared in the February issue of the journal New England Journal of Medicine.
The study included about 8,000 more children n of 249 research centers around the world. The researchers used centers in the United States and Europe, the Middle East and Asia.
The children ranged in age between 6 and 59 months were classified as randomly assigned to receive some of the traditional way vaccination by injection while others received the vaccination through nasal sprays, which bear the trade name Flomist.
Say plush that there are more of a reason why the new method is better than traditional, and these reasons that when spraying the vaccine in the nose, the immune system begins with the deployment of defenses in places that are more in need has a nose and respiratory system which places began to spread of infection because the flu virus is transmitted through the air to and from the nose to the rest of the respiratory system.
Also, this type of vaccine provides protection for many different strains of the disease.
But the plush warned of using this type of vaccination with children under the age of diagnosed lead to wheeze in the chest.
He also noted that the plush whiz could make it better not to use the new method with the Victims of respiratory crisis.
"The flu of the most dangerous diseases in young children as these are considered the main cause of transmission to family members."
ليست هناك تعليقات:
إرسال تعليق